| 000 | 01632 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514002156.0 | ||
| 264 | 0 | _c20020107 | |
| 008 | 200201s 0 0 eng d | ||
| 022 | _a0724-8741 | ||
| 024 | 7 |
_a10.1023/a:1011080418027 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCisternino, S | |
| 245 | 0 | 0 |
_aScreening of multidrug-resistance sensitive drugs by in situ brain perfusion in P-glycoprotein-deficient mice. _h[electronic resource] |
| 260 |
_bPharmaceutical research _cFeb 2001 |
||
| 300 |
_a183-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xdeficiency |
| 650 | 0 | 4 |
_aAcridines _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aBiological Transport |
| 650 | 0 | 4 | _aBlood-Brain Barrier |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 |
_aColchicine _xpharmacokinetics |
| 650 | 0 | 4 |
_aCyclosporins _xpharmacology |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacokinetics |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple _xphysiology |
| 650 | 0 | 4 |
_aIsoquinolines _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aPerfusion |
| 650 | 0 | 4 | _aTetrahydroisoquinolines |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVerapamil _xpharmacology |
| 650 | 0 | 4 |
_aVinblastine _xpharmacokinetics |
| 700 | 1 | _aRousselle, C | |
| 700 | 1 | _aDagenais, C | |
| 700 | 1 | _aScherrmann, J M | |
| 773 | 0 |
_tPharmaceutical research _gvol. 18 _gno. 2 _gp. 183-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1023/a:1011080418027 _zAvailable from publisher's website |
| 999 |
_c11335606 _d11335606 |
||